题名

心血管疾病改善之經濟效益分析-旅行成本法之應用

并列篇名

Evaluating the Benefits of Ameliorating Cardiovascular Disease-An Application of the Travel Cost Method

DOI

10.29765/TEI.201001.0003

作者

李杰憲(Chieh-Hsien Lee)

关键词

心血管疾病 ; 風險因子 ; 旅行成本法 ; 截斷式負二項模型 ; Cardiovascular Disease ; Risk Factors ; Travel Cost Method ; Truncated Negative Binomial Model

期刊名称

經濟研究

卷期/出版年月

46卷1期(2010 / 01 / 31)

页次

103 - 140

内容语文

繁體中文

中文摘要

本文引用旅行成本法(travel cost method)的概念,運用截斷式負二項模型(truncated negative binomial model)估計含有健康指標(血壓值、膽固醇值、血糖值、肥胖值)的醫療照護需求函數,並藉由觀察醫療照護需求的變化,探討改善心血管疾病的風險因子(高血壓,高膽固醇、糖尿病、肥胖)時,所能產生的經濟效益。實證結果顯示,以台閩地區而言,在考量患者的直接及間接醫療成本時,分別改善心血管疾病罹病者的血壓值、膽固醇值、血糖值、肥胖值狀況至平常人的水準,則健康指標改善總效益分別爲360億元、355億元、309億元、241億元。只考量直接醫療成本時,健康指標改善總效益分別爲317億元、313億元、272億元、212億元。若考量健康指標降到臨界值之健康指標改善效益,健康指標改善總效益分別爲125億元、242億元、145億元、97億元。

英文摘要

This paper uses the Travel Cost Method (TCM) to evaluate the benefits from ameliorating cardiovascular disease. Data from the CVDFACTS project and NHI are used for the empirical analysis. Results using the truncated negative binomial regression model show that if we can ameliorate risk factors, such as hypertension, cholesterol, diabetes and obesity, among cardiovascular disease sufferers so that the risk levels are no higher than found in the general population the Benefits of Ameliorating Disease are cost of medical service can be reduced NT$ 36.0, 35.5, 30.9 and 24.1 billion respectively. It is believed that research the benefits from ameliorating cardiovascular disease researcher and policy executor for caring about should have reference value.

主题分类 社會科學 > 經濟學
参考文献
  1. 李杰憲、傅祖壇(2008)。心血管疾病之改善效益衡量-特徵價格法之應用。經濟論文叢刊,36(1),1-37。
    連結:
  2. 竺凱、鄭蕙燕(2005)。台灣東部賞鯨旅遊之登船港口遊憩效益評估。農業經濟半年刊,77,45-67。
    連結:
  3. 陳凱莉、林雲雀(2005)。不同旅遊需求設定下之遊憩效益之比較-以宜蘭縣爲例。農業與經濟,34,91-120。
    連結:
  4. 傅祖壇、李杰憲(2006)。改善心血管疾病之效益衡量-群體歸因風險模式之應用。經濟研究,42(2),151-182。
    連結:
  5. 傅祖壇、劉錦添、簡錦漢、賴文龍(2001)。健康風認知與香菸消費行爲-台灣的實證研究。經濟論文,29(1),91-118。
    連結:
  6. 黃錦煌、蕭伯勳、葉純菊(2006)。台灣咖啡節遊憩效益評估之研究。戶外遊憩研究,19(3),1-21。
    連結:
  7. Alberini, A.,L. Alberto(2005).The Value of Cultural Heritage Sites in Armenia: Evidence from a Travel Cost Method Study.FEEM Working Paper No.112.
  8. Anderson, K. M.,P. M. Odell,P. W. F. Wilson,W. B. Kannel(1991).Cardiovascular Disease Risk Profiles.American Heart Journal,121,293-298.
  9. Antoni, R. F.(2000).Mass Tourism and the Demand for Protected Natural Areas: A Travel Cost Approach.Journal of Environmental Economics and Management,39,97-116.
  10. Arrow, J. P.(1963).Uncertainty and the Welfare Economics of Medical Care.American Economic Review,53,941-973.
  11. Becker, G.(1965).A Theory of the Allocation of Time.Economic Journal,75,493-517.
  12. Brockett, P. L.,L. L. Golden,H. H. Panjer(1996).Flexible Purchase Frequency Modeling.Journal of Marketing Research,33,94-107.
  13. Cauly, S. D.(1987).The Time Price of Medical Care.Review of Economics and Statistices,69(1),59-66.
  14. Cesario, F. J.(1974).More on the Generalized Trip Distribution Model.Journal of Regional Science,41(3),389-397.
  15. Cesario, F. J.,J. L. Kentsch(1976).A Recreation Site Demand and Benefit Estimation Model.Regional Studies,10,97-104.
  16. Clarke, P. M.(2002).Testing the Convergent Validity of the Contingent Valuation and Travel Cost Methods in Valuing the Benefits of Health Care.Health Economics,11(2),117-127.
  17. Clawson, M.(1959).Methods of Measuring the Demand for and Value of Outdoor Recreation.Washington, D. C.:Resources for the Future.
  18. Dardanoni, V.,A. Wagstaff(1990).Uncertainty and the Demand for Medical Care.Journal of Health Economics,9(1),22-38.
  19. Ehrenberg, A. S. C.(1988).Repeat Buying.New York:Oxford University Press.
  20. Ehrenberg, A. S. C.(1959).The Pattern of Consumer Purchases.Applied Statistics,8(1),26-41.
  21. Gaziano, T. A.(2008).Economic Burden and the Cost-Effectiveness of Treatment of Cardiovascular Diseases in Africa.Heart,94(2),140-144.
  22. Getzen, T. E.(2002).Health Care Is an Individual Necessity and a National Luxury: Applying Multilevel Decision Model to the Analysis of Health Care Expenditures.Journal of Health Economics,19(2),259-270.
  23. Groot, W.,M. B. Henriette,P. Erik(2004).Money for Health: The Equivalent Variation of Cardiovascular Diseases.Health Economics,13(9),859-872.
  24. Grossman, M.(1972).On the Concept of Health Capital and the Demand for Health.Journal of Political Economy,80,223-255.
  25. Hotelling, H.(1947).Studies of Outdoor Recreation.Washington, D. C.:Outdoor Recreation Review Commission.
  26. Jochmann, M.,R. L. Gonzalez(2004).Estimating the Demand for Health Care with Panel Data: A Semiparametric Bayesian Approach.Health Economics,13(10),1003-1014.
  27. Kannel, W. B.,W. P. Castelli,T. Gordon,P. M. Mcnammara(1984).Optimal Resources for Primary Prevention of Atherosclerotic Disease Resource.Circulation,70(1),157-205.
  28. Kenkel, D. S.(1991).Health Behavior, Health Knowledge, and Schooling.Journal of Political Economy,99(2),287-305.
  29. Khan, H.(2006).Willingness to Pay for Margalla Hills National Park: Evidence from the Travel Cost Method.Lahore Journal of Economics,11(2),43-70.
  30. Liu, J. T.,C. R. Hsieh(1995).Risk Perception and Smoking Behavior: Empirical Evidence from Taiwan.Journal of Risk and Uncertainty,11,139-157.
  31. Massy, W. F.,D. B. Montgomery,D. G. Morrison(1970).Stochastic Models of Buying Behavior.MA:The MIT Press.
  32. McConnell, K. E.(1975).Some Problems in Estimating the Demand for Outdoor Recreation.American Journal of Agricultural Economics,57,330-334.
  33. Morrison, D. G.,D. C. Schmittlein(1988).Generalizing the NBD Model for Customer Purchases: What Are the Implications and Is It Worth the Effect?.Journal of Business and Economic Statistics,6,145-159.
  34. Newhouse, P. J.,G. M. Manning,N. C. Morris(1982).Some Interim Result from a Controlled Trial of Cost-Sharing in Health Insurance.New England Journal of Medicine,305(25),1501-1507.
  35. Rice, D. P.,T. A. Hodgson,P. Sinsheimer,W. Browner,A. N. Kopstein(1986).The Economic Cost of the Health Effects of Smoking.The Milbank Quarterly,64(4),489-547.
  36. Sindelar, J. L.(1982).Differential Use of Medical Care by Sex.Journal of Political Economy,90(5),1003-1019.
  37. Suhrcke, M.,D. M. Urban(2006).Are Cardiovascular Diseases Bad for Economic Growth?.CESifo Working Paper No. 1845.
  38. Taylor, T. N.,P. H. Davis,J. C. Torner,J. Holmes,J. W. Meyer,M. F. Jacobson(1996).Lifetime Costs of Stroke in the United States.Stroke,27(9),1459-1466.
  39. Trogdon, J. G.,E. A. Finkelstein,I. A. Nwaise,F. K. Tangka,D. Orenstein(2007).The Economic Burden of Chronic Cardiovascular Disease for Major Insurers.Health Promotion Practice,8(3),234-242.
  40. Viscusi, W. K.(1990).Do Smoker Underestimate Risks?.Journal of Political Economics,98,1253-1269.
  41. WHO(1980).The International Classification of Diseases.
  42. Wilson, P. W. F.,R. B. D''Agostino,D. Levy,A. M. Belanger,H. Silbershatz,W. B. Kannel(1998).Prediction of Coronary Heart Disease Using Risk Factor Categories.Circulation,97,1897-1847.
  43. Wood, S.,A. Trice(1958).Measurement of Recreation Benefits.Land Eonomics,34(3),195-207.
  44. Wu, S. T.,F. S. Hsu(1989).A Estimation of Recreational Benefit from Water Quality Improvement, the Case of River Tamsuei.paper presented at Sino-Us Bi-national Conference on Environmental Protection and Social Development,Taipei, Taiwan:
  45. 內政部(2006)。婦女生活狀況調查抽樣設計。
  46. 行政院衛生署(2002)。台灣地區主要死亡分析。
  47. 林璟鈺(1999)。碩士論文(碩士論文)。國防醫學院公共衛生學研究所。
  48. 許振榮(2001)。碩士論文(碩士論文)。台灣大學公共衛生學研究所。
  49. 陳凱俐、溫育芳(1995)。遊憩區經濟效益評估法之應用-以國立宜蘭農工專科學校實驗林場爲例。農業經濟叢刊,1(1),87-116。
  50. 黃一展(1995)。碩士論文(碩士論文)。台灣大學公共衛生學研究所。
  51. 黃宗煌(1989)。台灣地區國家公園之遊憩效益的評估。台灣銀行季刊,41(3),283-304。
  52. 潘文涵(1999)。竹東及朴子地區心血管疾病長期追蹤研究。第五循環計畫。
  53. 潘文涵(2002)。心臟血管疾病之社區追蹤整合研究-致病機轉、社會因素、統計模型、及經濟效益評估。中央研究院主題研究與高級人才培育之主題計畫。
  54. 蕭代基(1988)。核能四廠計畫社會效益及成本分析:(15)對遊憩價值之影響。台灣電力公司委託研究計畫。